NGS analysis revealed that a subset of the NF-κB/RELA target genes was synergistically suppressed, and expression levels of a series of tumor suppressor genes were elevated by the co-targeting EGFR and IKK with specific small molecule inhibitors. The gene discussed is EGFR; the disease is neoplasm.